These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 23280478

  • 1. Radiation therapy target volume reduction in pediatric rhabdomyosarcoma: implications for patterns of disease recurrence and overall survival.
    Eaton BR, McDonald MW, Kim S, Marcus RB, Sutter AL, Chen Z, Esiashvili N.
    Cancer; 2013 Apr 15; 119(8):1578-85. PubMed ID: 23280478
    [Abstract] [Full Text] [Related]

  • 2. Intensity-modulated radiotherapy with use of cone-down boost for pediatric head-and-neck rhabdomyosarcoma.
    McDonald MW, Esiashvili N, George BA, Katzenstein HM, Olson TA, Rapkin LB, Marcus RB.
    Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):884-91. PubMed ID: 18455321
    [Abstract] [Full Text] [Related]

  • 3. Delayed radiotherapy following dose intensive chemotherapy for parameningeal rhabdomyosarcoma (PM-RMS) of childhood.
    Douglas JG, Arndt CA, Hawkins DS.
    Eur J Cancer; 2007 Apr 01; 43(6):1045-50. PubMed ID: 17368885
    [Abstract] [Full Text] [Related]

  • 4. Local control of parameningeal rhabdomyosarcoma: outcomes in non-complete responders to chemoradiation.
    Paulino AC, Bauman N, Simon JH, Nguyen TX, Ritchie JM, Tannous R.
    Med Pediatr Oncol; 2003 Aug 01; 41(2):118-22. PubMed ID: 12825215
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Parameningeal rhabdomyosarcoma: outcomes and opportunities.
    Yang JC, Wexler LH, Meyers PA, Wolden SL.
    Int J Radiat Oncol Biol Phys; 2013 Jan 01; 85(1):e61-6. PubMed ID: 23021437
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
    Curtis AE, Okcu MF, Chintagumpala M, Teh BS, Paulino AC.
    Int J Radiat Oncol Biol Phys; 2009 Jan 01; 73(1):173-7. PubMed ID: 18501529
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intensity modulated radiation therapy with dose painting to treat rhabdomyosarcoma.
    Yang JC, Dharmarajan KV, Wexler LH, La Quaglia MP, Happersett L, Wolden SL.
    Int J Radiat Oncol Biol Phys; 2012 Nov 01; 84(3):e371-7. PubMed ID: 22658517
    [Abstract] [Full Text] [Related]

  • 13. Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma.
    Wolden SL, La TH, LaQuaglia MP, Meyers PA, Kraus DH, Wexler LH.
    Cancer; 2003 Jan 01; 97(1):179-85. PubMed ID: 12491519
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
    Bahri S, Flickinger JC, Kalend AM, Deutsch M, Belani CP, Sciurba FC, Luketich JD, Greenberger JS.
    Radiat Oncol Investig; 1999 Jan 01; 7(5):297-308. PubMed ID: 10580899
    [Abstract] [Full Text] [Related]

  • 17. Central nervous system relapse of rhabdomyosarcoma.
    De B, Kinnaman MD, Wexler LH, Kramer K, Wolden SL.
    Pediatr Blood Cancer; 2018 Jan 01; 65(1):. PubMed ID: 28696016
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of nonmetastatic cranial parameningeal rhabdomyosarcoma in children younger than 3 years old: results from international society of pediatric oncology studies MMT 89 and 95.
    Defachelles AS, Rey A, Oberlin O, Spooner D, Stevens MC.
    J Clin Oncol; 2009 Mar 10; 27(8):1310-5. PubMed ID: 19204197
    [Abstract] [Full Text] [Related]

  • 20. [Improved local tumor control by early and risk-adjusted use of radiotherapy in primary non-resectable rhabdomyosarcomas: results of CWS 81 and 86 studies].
    Koscielniak E, Herbst M, Niethammer D, Treuner J.
    Klin Padiatr; 1994 Mar 10; 206(4):269-76. PubMed ID: 7967423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.